598 related articles for article (PubMed ID: 14768402)
1. Paclitaxel and gemcitabine as salvage treatment in metastatic breast cancer.
Murad AM
Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):26-32. PubMed ID: 14768402
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine/paclitaxel as first-line treatment of advanced breast cancer.
Delfino C; Caccia G; Riva Gonzáles L; Mickiewicz E; Rodger J; Balbiani L; Flores Morales D; Zori Comba A; Brosio C
Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):22-5. PubMed ID: 14768401
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer.
Sledge GW
Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):33-5. PubMed ID: 14768403
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of the use of paclitaxel and gemcitabine as a salvage treatment in metastatic breast cancer.
Murad AM; Guimarães RC; Aragão BC; Scalabrini-Neto AO; Rodrigues VH; Garcia R
Am J Clin Oncol; 2001 Jun; 24(3):264-8. PubMed ID: 11404498
[TBL] [Abstract][Full Text] [Related]
5. High activity of salvage treatment with biweekly paclitaxel-gemcitabine combination in heavily pretreated breast cancer patients.
Vici P; Capomolla E; Foggi P; Carpano S; Conti F; Paoletti G; Cauchi C; Giacinti L; Leonetti C; Giannarelli D; Lopez M
J Exp Clin Cancer Res; 2006 Mar; 25(1):39-44. PubMed ID: 16761616
[TBL] [Abstract][Full Text] [Related]
6. Weekly paclitaxel combining with gemcitabine is an effective and safe treatment for advanced breast cancer patients.
Rau KM; Li SH; Chen SM; Tang Y; Huang CH; Wu SC; Chen YY
Jpn J Clin Oncol; 2011 Apr; 41(4):455-61. PubMed ID: 21193489
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
8. Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group.
Mavroudis D; Malamos N; Alexopoulos A; Kourousis C; Agelaki S; Sarra E; Potamianou A; Kosmas C; Rigatos G; Giannakakis T; Kalbakis K; Apostolaki F; Vlachonicolis J; Kakolyris S; Samonis G; Georgoulias V
Ann Oncol; 1999 Feb; 10(2):211-5. PubMed ID: 10093691
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of trastuzumab plus gemcitabine in chemotherapy-pretreated patients with metastatic breast cancer.
O'Shaughnessy JA; Vukelja S; Marsland T; Kimmel G; Ratnam S; Pippen JE
Clin Breast Cancer; 2004 Jun; 5(2):142-7. PubMed ID: 15245619
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel albumin-bound particles (abraxane) in combination with bevacizumab with or without gemcitabine: early experience at the University of Miami/Braman Family Breast Cancer Institute.
Lobo C; Lopes G; Silva O; Gluck S
Biomed Pharmacother; 2007 Oct; 61(9):531-3. PubMed ID: 17913443
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).
Fountzilas G; Christodoulou C; Tsavdaridis D; Kalogera-Fountzila A; Aravantinos G; Razis E; Kalofonos HP; Papakostas P; Karina M; Gogas H; Skarlos D
Cancer Invest; 2004; 22(5):655-62. PubMed ID: 15581045
[TBL] [Abstract][Full Text] [Related]
12. [Metastatic breast cancer: new chemotherapy regimens with taxanes].
Lopez M
Clin Ter; 2005; 156(6):311-5. PubMed ID: 16463568
[TBL] [Abstract][Full Text] [Related]
13. Biweekly paclitaxel and gemcitabine for patients with advanced urothelial cancer ineligible for cisplatin-based regimen.
Takahashi T; Higashi S; Nishiyama H; Segawa T; Nakamura E; Kinoshita H; Itoh N; Yamamoto S; Kamoto T; Habuchi T; Ogawa O
Jpn J Clin Oncol; 2006 Feb; 36(2):104-8. PubMed ID: 16418182
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure.
Demiray M; Kurt E; Evrensel T; Kanat O; Arslan M; Saraydaroglu O; Ercan I; Gonullu G; Gokgoz S; Topal U; Tolunay S; Tasdelen I; Manavoglu O
Cancer Invest; 2005; 23(5):386-91. PubMed ID: 16193637
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer.
Miller KD; Sisk J; Ansari R; Gize G; Nattam S; Pennington K; Monaco F; Sledge GW
Oncology (Williston Park); 2001 Feb; 15(2 Suppl 3):38-40. PubMed ID: 11252888
[TBL] [Abstract][Full Text] [Related]
16. Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer.
Cinieri S; Chan A; Altundag K; Vandebroek A; Tubiana-Mathieu N; Barnadas A; Dodyk P; Lazzarelli S; Botha M; Rauch D; Villanova G; Coskun U
Clin Breast Cancer; 2017 Apr; 17(2):91-99.e1. PubMed ID: 27756583
[TBL] [Abstract][Full Text] [Related]
17. Intravenous 3-weekly paclitaxel and metronomic oral cyclophosphamide in patients with advanced urothelial cancer previously treated with gemcitabine and platinum.
Park JH; Lee JL
Cancer Chemother Pharmacol; 2015 Feb; 75(2):247-54. PubMed ID: 25428517
[TBL] [Abstract][Full Text] [Related]
18. Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer.
Bartsch R; Wenzel C; Gampenrieder SP; Pluschnig U; Altorjai G; Rudas M; Mader RM; Dubsky P; Rottenfusser A; Gnant M; Zielinski CC; Steger GG
Cancer Chemother Pharmacol; 2008 Oct; 62(5):903-10. PubMed ID: 18256835
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine plus paclitaxel as first-line chemotherapy for patients with advanced breast cancer.
Delfino C; Caccia G; Gonzáles LR; Mickiewicz E; Rodger J; Balbiani L; Morales DF; Comba AZ; Brosio C
Oncology; 2004; 66(1):18-23. PubMed ID: 15031594
[TBL] [Abstract][Full Text] [Related]
20. Experience with single-agent paclitaxel consolidation following primary chemotherapy with carboplatin, paclitaxel, and gemcitabine in advanced ovarian cancer.
Micha JP; Goldstein BH; Mattison JA; Bader K; Graham C; Rettenmaier MA; Brown JV; Markman M
Gynecol Oncol; 2005 Jan; 96(1):132-5. PubMed ID: 15589591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
